Healthcare provider profile · identity verified

Mackenzie Rae Lobitz, M. D.

Family Practice · GLENCOE, MN · NPI 1770841504

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	241	61
Lisinopril	Lisinopril	185	45
Omeprazole	Omeprazole	166	52
Levothyroxine Sodium	Levothyroxine Sodium	165	45
Amlodipine Besylate	Amlodipine Besylate	144	37
Losartan Potassium	Losartan Potassium	126	41
Gabapentin	Gabapentin	125	42
Metoprolol Succinate	Metoprolol Succinate	113	32
Furosemide	Furosemide	107	39
Lorazepam	Lorazepam	100	15
Simvastatin	Simvastatin	100	30
Eliquis	Apixaban	94	16
Trazodone Hcl	Trazodone Hcl	93	29
Hydrochlorothiazide	Hydrochlorothiazide	92	26
Warfarin Sodium	Warfarin Sodium	90	12
Potassium Chloride	Potassium Chloride	88	22
Metoprolol Tartrate	Metoprolol Tartrate	84	23
Citalopram Hbr	Citalopram Hydrobromide	74	18
Pantoprazole Sodium	Pantoprazole Sodium	74	22
Fluticasone Propionate	Fluticasone Propionate	72	24
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	72	13
Montelukast Sodium	Montelukast Sodium	68	30
Metformin Hcl	Metformin Hcl	67	21
Rosuvastatin Calcium	Rosuvastatin Calcium	66	23
Famotidine	Famotidine	63	18
Escitalopram Oxalate	Escitalopram Oxalate	62	21
Pregabalin	Pregabalin	62	20
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	59	suppressed
Mirtazapine	Mirtazapine	56	suppressed
Tramadol Hcl	Tramadol Hcl	55	15
Zolpidem Tartrate	Zolpidem Tartrate	55	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	54	33
Duloxetine Hcl	Duloxetine Hcl	49	16
Ropinirole Hcl	Ropinirole Hcl	49	12
Tamsulosin Hcl	Tamsulosin Hcl	48	12
Bupropion Xl	Bupropion Hcl	46	11
Sertraline Hcl	Sertraline Hcl	46	11
Metformin Hcl Er	Metformin Hcl	44	18
Triamcinolone Acetonide	Triamcinolone Acetonide	44	25
Glipizide	Glipizide	43	13
Spironolactone	Spironolactone	43	11
Torsemide	Torsemide	43	suppressed
Atenolol	Atenolol	42	suppressed
Alendronate Sodium	Alendronate Sodium	39	15
Hydroxyzine Hcl	Hydroxyzine Hcl	39	suppressed
Tizanidine Hcl	Tizanidine Hcl	37	suppressed
Breo Ellipta	Fluticasone/Vilanterol	35	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	35	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	33	14
Carvedilol	Carvedilol	32	11
Clonazepam	Clonazepam	32	suppressed
Digoxin	Digoxin	32	suppressed
Topiramate	Topiramate	31	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	30	11
Estradiol	Estradiol	29	suppressed
Metolazone	Metolazone	29	suppressed
Cephalexin	Cephalexin	28	16
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	28	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	27	suppressed
Jardiance	Empagliflozin	27	suppressed
Levetiracetam	Levetiracetam	27	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	27	suppressed
Allopurinol	Allopurinol	26	suppressed
Buspirone Hcl	Buspirone Hcl	26	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	26	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	26	suppressed
Ventolin Hfa	Albuterol Sulfate	26	suppressed
Celecoxib	Celecoxib	25	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	25	suppressed
Mounjaro	Tirzepatide	24	suppressed
Nystatin	Nystatin	24	suppressed
Ozempic	Semaglutide	24	suppressed
Linzess	Linaclotide	23	suppressed
Loperamide	Loperamide Hcl	23	suppressed
Prednisone	Prednisone	23	19
Trulicity	Dulaglutide	23	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	22	suppressed
Fluconazole	Fluconazole	21	13
Latanoprost	Latanoprost	21	suppressed
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Amoxicillin	Amoxicillin	20	13
Divalproex Sodium	Divalproex Sodium	20	suppressed
Insulin Aspart Flexpen	Insulin Aspart	20	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	20	11
Pravastatin Sodium	Pravastatin Sodium	19	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Tresiba Flextouch U-100	Insulin Degludec	19	suppressed
Baclofen	Baclofen	18	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Sotalol	Sotalol Hcl	17	suppressed
Clotrimazole	Clotrimazole	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	14	suppressed
Flecainide Acetate	Flecainide Acetate	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Azithromycin	Azithromycin	13	suppressed
Clopidogrel	Clopidogrel Bisulfate	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Estradiol (Once Weekly)	Estradiol	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Incruse Ellipta	Umeclidinium Bromide	13	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	13	suppressed
Norethindrone	Norethindrone	13	suppressed
Prazosin Hcl	Prazosin Hcl	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	12	suppressed
Varenicline Tartrate	Varenicline Tartrate	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error